Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sandoz’s Erelzi available for multiple inflammatory disease treatment in Canada

pharmaceutical-technologyAugust 23, 2017

Tag: Novartis , Erelzi , inflammatory disease

PharmaSources Customer Service